<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2024 (6) TMI 387 - CESTAT BANGALORE</title>
    <link>https://www.taxtmi.com/caselaws?id=753780</link>
    <description>CESTAT Bangalore rejected appellant&#039;s claim for refund of interest paid on proportionate credit reversed under retrospective amendment to Rule 6 of CCR 2002/2004. The tribunal held that once interest was paid to comply with Section 72 of Finance Act 2010&#039;s retrospective amendment requirements, no refund was permissible as the statutory provision mandated interest payment without considering credit utilization. However, CESTAT allowed interest on excess credit of Rs.1,00,10,808 from three months after refund filing date (17.9.2011 to 21.11.2019) following Supreme Court precedent in Ranbaxy Laboratories. Appeal partially allowed with modified orders.</description>
    <language>en-us</language>
    <pubDate>Mon, 08 Apr 2024 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 10 Jun 2024 16:55:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=755939" rel="self" type="application/rss+xml"/>
    <item>
      <title>2024 (6) TMI 387 - CESTAT BANGALORE</title>
      <link>https://www.taxtmi.com/caselaws?id=753780</link>
      <description>CESTAT Bangalore rejected appellant&#039;s claim for refund of interest paid on proportionate credit reversed under retrospective amendment to Rule 6 of CCR 2002/2004. The tribunal held that once interest was paid to comply with Section 72 of Finance Act 2010&#039;s retrospective amendment requirements, no refund was permissible as the statutory provision mandated interest payment without considering credit utilization. However, CESTAT allowed interest on excess credit of Rs.1,00,10,808 from three months after refund filing date (17.9.2011 to 21.11.2019) following Supreme Court precedent in Ranbaxy Laboratories. Appeal partially allowed with modified orders.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 08 Apr 2024 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=753780</guid>
    </item>
  </channel>
</rss>